Pharminox Ltd
www.pharminox.com
Pharminox is focused on the discovery and development of novel small molecule drugs for the treatment of cancer. In early 2004, Malcolm Stevens, Director of the Cancer Research UK Experimental Cancer Chemotherapy Group, joined Pharminox as Chief Scientific Officer. Their discovery activities are now based at their new laboratories at the BioCity facility in the centre of Nottingham.